Bupropion/Naltrexone

Contrave · Mysimba

Ancillary GLP-1 Published Clinical Data

Overview

Combination of bupropion (norepinephrine/dopamine reuptake inhibitor) and naltrexone (opioid antagonist). FDA-approved for chronic weight management. Stacked with GLP-1 agonists in community protocols targeting food noise and cravings when GLP-1 alone is insufficient.

Used in Regimens

Bupropion/Naltrexone is not currently part of any catalog regimen.

Related Tools

Track Bupropion/Naltrexone with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.